Vitamin B2-mediated cellular photoinhibition of botulinum neurotoxin A

FEBS Letters

Volumn 579, Issue 24, 2005, Pages 5361-5364

  Eubanks, Lisa M ^a   Dickerson, Tobin J ^a   Janda, Kim D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Bioterrorism; Botulinum neurotoxin; Photodynamic therapy; Riboflavin

Indexed keywords

BOTULINUM TOXIN A; RIBOFLAVIN; TRACE ELEMENT;

ANIMAL CELL; ARTICLE; CELL ASSAY; CONTROLLED STUDY; NEUROTOXICITY; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOINHIBITION; PHOTOOXIDATION; PRIORITY JOURNAL; RAT; ANIMAL; BIOLOGICAL WARFARE; CELL STRAIN; DRUG ANTAGONISM; PHOTOCHEMISTRY;

ANIMALS; BIOTERRORISM; BOTULINUM TOXIN TYPE A; PC12 CELLS; PHOTOCHEMISTRY; RATS; RIBOFLAVIN;

EID: 25844466999     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2005.08.072     Document Type: Article

References (26)

1. J.M. Madsen Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents Clin. Lab. Med. 21 2001 593 605
2. B.R. Singh Biomedical and toxico-chemical aspects of botulinum neurotoxin J. Toxicol. Toxin Rev. 18 1999 vii x
3. S.S. Arnon, R. Schechter, T.V. Inglesby, D.A. Henderson, J.G. Bartlett, M.S. Ascher, E. Eitzen, A.D. Fine, J. Hauer, M. Layton, S. Lillibridge, M.T. Osterholm, T. O'Toole, G. Parker, T.M. Perl, P.K. Russell, D.L. Swerdlow, and K. Tonat Botulinum toxin as a biological weapon: medical and public health management JAMA 285 2001 1059 1070
4. H. Sugiyama Clostridium botulinum neurotoxin Microbiol. Rev. 44 1980 419 448
5. M.P. Byrne, and L.A. Smith Development of vaccines for prevention of botulism Biochimie 82 2000 955 966
6. L.A. Smith Development of recombinant vaccines for botulinum neurotoxin Toxicon 36 1998 1539 1548
7. R.E. Black, and R.A. Gunn Hypersensitivity reactions associated with botulinal antitoxin Am. J. Med. 69 1980 567 570
8. C.O. Tacket, W.X. Shandera, J.M. Mann, N.T. Hargrett, and P.A. Blake Equine antitoxin use and other factors that predict outcome in type A foodborne botulism Am. J. Med. 76 1984 794 798
9. C.O. Martin, and H.P. Adams Neurological aspects of biological and chemical terrorism: a review for neurologists Arch. Neurol. 60 2003 21 25
10. L.C. Sellin, J.A. Kauffman, and B.R. DasGupta Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction Med. Biol. 61 1983 120 125
11. M.B. Taylor, and G.K. Radda Flavins as photosensitizers Meth. Enzymol. 18 1971 496 506
12. W.M. Moore, J.T. Spence, F.A. Raymond, and S.D. Colson Photochemistry of riboflavin. I. The hydrogen transfer process in the anaerobic photobleaching of flavins J. Am. Chem. Soc. 85 1963 3367 3372
13. E.J. Schantz, D. Stefanye, and L. Spero Observations on the fluorescence and toxicity of botulinum toxin J. Biol. Chem. 235 1960 3489 3491
14. D.A. Boroff, and B.R. DasGupta Study of the toxin of Clostridium botulinum. VII. Relation of tryptophan to the biological activity of the toxin J. Biol. Chem. 239 1964 3694 3698
15. D.A. Boroff, B.R. DasGupta, and U.S. Fleck Chemistry and biologic activity of the toxin of Clostridium botulinum J. Albert Einstein Medical Center 15 1967 22 34
16. M. Wainwright, and K.B. Crossley Methylene blue - a therapeutic dye for all seasons? J. Chemother. 14 2002 431 443
17. M. Wainwright, and L. Amaral The phenothiazinium chromophore and the evolution of antimalarial drugs Trop. Med. Int. Health 10 2005 501 511
18. T. Binz, J. Blasi, S. Yamasaki, A. Baumeister, E. Link, T.C. Sudhof, R. Jahn, and H. Niemann Proteolysis of SNAP-25 by types E and A botulinal neurotoxins J. Biol. Chem. 269 1994 1617 1620
19. J.E. Keller, E.A. Neale, G. Oyler, and M. Adler Persistence of botulinum neurotoxin action in cultured spinal cord cells FEBS Lett. 456 1999 137 142
20. S.S. Deshpande, R.E. Sheridan, and M. Adler A study of zinc-dependent metalloendopeptidase inhibitors as pharmacological antagonists in botulinum neurotoxin poisoning Toxicon 33 1995 551 557
21. L.A. Greene, and A.S. Tischler Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor Proc. Natl. Acad. Sci. USA 73 1976 2424 2428
22. B.C. Yowler, R.D. Kensinger, and C.-L. Schengrund Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I J. Biol. Chem. 277 2002 32815 32819
23. J.E. Keller, F. Cai, and E.A. Neale Uptake of botulinum neurotoxin into cultured neurons Biochemistry 43 2004 526 532
24. J.G. Levy, and M. Obochi New applications in photodynamic therapy. Introduction Photochem. Photobiol. 64 1996 737 739
25. R. Bonnett, and G. Martínez Photobleaching of sensitizers used in photodynamic therapy Tetrahedron 57 2001 9513 9547
26. Z. Huang A review of progress in clinical photodynamic therapy Technol. Cancer Res. Treat. 4 2005 283 293